Thalidomide-5-propargyne-NH2 hydrochloride
98%
- Product Code: 63060
CAS:
2490402-62-3
| Molecular Weight: | 347.75 g./mol | Molecular Formula: | C₁₆H₁₄ClN₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Thalidomide-5-propargyne-NH2 hydrochloride is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of targeted therapeutic agents, particularly in the design of proteolysis-targeting chimeras (PROTACs). These molecules are engineered to selectively degrade disease-causing proteins by leveraging the ubiquitin-proteasome system. This compound’s structure allows for the incorporation of functional groups that enhance binding affinity and specificity to target proteins, making it valuable in the development of treatments for cancers, autoimmune diseases, and other conditions driven by aberrant protein activity. Additionally, its propargyl group enables further chemical modifications through click chemistry, facilitating the creation of complex drug candidates with improved pharmacokinetic properties.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿23,040.00 |
+
-
|
| 0.005 | 10-20 days | ฿66,240.00 |
+
-
|
Thalidomide-5-propargyne-NH2 hydrochloride
Thalidomide-5-propargyne-NH2 hydrochloride is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of targeted therapeutic agents, particularly in the design of proteolysis-targeting chimeras (PROTACs). These molecules are engineered to selectively degrade disease-causing proteins by leveraging the ubiquitin-proteasome system. This compound’s structure allows for the incorporation of functional groups that enhance binding affinity and specificity to target proteins, making it valuable in the development of treatments for cancers, autoimmune diseases, and other conditions driven by aberrant protein activity. Additionally, its propargyl group enables further chemical modifications through click chemistry, facilitating the creation of complex drug candidates with improved pharmacokinetic properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :